Maxivision unveils Breakthrough Research in Eye-care

Maxivision unveils Breakthrough Research in Eye-care

Hyderabad, 4 July 2018: Hyderabad-based Maxivision Super-specialty Eye Hospitals have revealed more research in glaucoma treatment, in the form of Micro-Invasive Glaucoma Surgery (MIGS).

 

The principal investigator was Dr. Kasu Prasad Reddy, Founder, Maxivision Group, with Dr. Anita K, Senior Consultant and Head, Glaucoma Services, Maxivision Eye Hospitals as the co-principal investigator. Experimentation was conducted under the guidance of Dr. Antonio Maria Fea, MD. - Ph.D., Aggregate Professor, Dipartimento di Scienze Chirurgiche Clinica Oculistica V. Juvarra 19, Torino.

 

“Glaucoma is one of the leading causes of permanent blindness and, unfortunately, approximately 10% of the people with glaucoma who receive proper treatment still experience loss of vision,” said Dr. Kasu Prasad Reddy, “Maxivision became the first and foremost hospital in India to successfully carry out MIGS surgery to treat glaucoma.” MIGS involves the use of the Miniject, an implant with a microporous structure, made of proprietary STAR® biomaterial (CE approved), which channels aqueous humour from the anterior chamber of the eye to the supra-choroidal space, reducing pressure in the eye. The implantation is swift and done using a trigger in a single-step procedure. So far, the device has been introduced into 25 patients, and according to the doctor, has shown amazing results with minimal complications.

 

Dr. Anita K. elaborated on the need for awareness of glaucoma in underdeveloped and developing countries. “As per reports, there are as many as 10 to 12 million people suffering from glaucoma in India every year. By the time the patient approaches the ophthalmologist, peripheral vision loss could have happened, and the damage can’t be refurbished.” She added, “Early diagnosis enables the ophthalmologists to protect the vision from further loss. Regular check-ups with the doctor and using the medicines can keep glaucoma at bay.”